Suppr超能文献

多重超选择性 PCR 检测法在液体活检中稀有体细胞突变的检测和定量。

Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies.

机构信息

Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.

ATGen, Montevideo, Uruguay.

出版信息

J Mol Diagn. 2022 Mar;24(3):189-204. doi: 10.1016/j.jmoldx.2021.11.006. Epub 2021 Dec 23.

Abstract

SuperSelective primers, by virtue of their unique design, enable the simultaneous identification and quantitation of inherited reference genes and rare somatic mutations in routine multiplex PCR assays, while virtually eliminating signals from abundant wild-type sequences closely related to the target mutations. These assays are sensitive, specific, rapid, and low cost, and can be performed in widely available spectrofluorometric thermal cyclers. Herein, we provide examples of SuperSelective PCR assays that target eight different somatic EGFR mutations, irrespective of whether they occur in the same codon, occur at separate sites within the same exon, or involve deletions. In addition, we provide examples of SuperSelective PCR assays that detect specific EGFR mutations in circulating tumor DNA present in the plasma of liquid biopsies obtained from patients with non-small-cell lung cancer. The results suggest that multiplex SuperSelective PCR assays may enable the choice, and subsequent modification, of effective targeted therapies for the treatment of an individual's cancer, utilizing frequent noninvasive liquid biopsies.

摘要

超选择性引物凭借其独特的设计,能够在常规多重 PCR 检测中同时鉴定和定量遗传性参考基因和罕见的体细胞突变,同时几乎消除了与目标突变密切相关的大量野生型序列的信号。这些检测方法灵敏、特异、快速且成本低廉,可在广泛应用的分光荧光热循环仪上进行。本文提供了针对 8 种不同 EGFR 体细胞突变的超选择性 PCR 检测方法的实例,无论这些突变是否发生在同一密码子中,是否发生在同一外显子的不同部位,或者是否涉及缺失。此外,本文还提供了检测非小细胞肺癌患者液体活检中循环肿瘤 DNA 中特定 EGFR 突变的超选择性 PCR 检测方法的实例。结果表明,多重超选择性 PCR 检测方法可能能够通过频繁的非侵入性液体活检,为个体癌症的治疗选择并随后修改有效的靶向治疗方法。

相似文献

1
Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies.
J Mol Diagn. 2022 Mar;24(3):189-204. doi: 10.1016/j.jmoldx.2021.11.006. Epub 2021 Dec 23.
2
Therapy Monitoring of EGFR-Positive Non-Small-Cell Lung Cancer Patients Using ddPCR Multiplex Assays.
J Mol Diagn. 2021 Apr;23(4):495-505. doi: 10.1016/j.jmoldx.2021.01.003. Epub 2021 Jan 22.
5
Multiplex Real-Time PCR Assays that Measure the Abundance of Extremely Rare Mutations Associated with Cancer.
PLoS One. 2016 May 31;11(5):e0156546. doi: 10.1371/journal.pone.0156546. eCollection 2016.
8
SuperSelective primer pairs for sensitive detection of rare somatic mutations.
Sci Rep. 2021 Nov 17;11(1):22384. doi: 10.1038/s41598-021-00920-4.
10
6-Color Crystal Digital PCR for the High-Plex Detection of EGFR Mutations in Non-Small Cell Lung Cancer.
Methods Mol Biol. 2021;2279:127-144. doi: 10.1007/978-1-0716-1278-1_10.

引用本文的文献

本文引用的文献

1
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16.
2
Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
Theranostics. 2020 Mar 26;10(11):4737-4748. doi: 10.7150/thno.42565. eCollection 2020.
3
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Nat Med. 2019 Dec;25(12):1928-1937. doi: 10.1038/s41591-019-0652-7. Epub 2019 Nov 25.
5
Mechanisms and clinical relevance of bacterial heteroresistance.
Nat Rev Microbiol. 2019 Aug;17(8):479-496. doi: 10.1038/s41579-019-0218-1. Epub 2019 Jun 24.
6
Quantifying circulating cell-free DNA in humans.
Sci Rep. 2019 Mar 26;9(1):5220. doi: 10.1038/s41598-019-41593-4.
7
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer.
Front Oncol. 2019 Mar 5;9:129. doi: 10.3389/fonc.2019.00129. eCollection 2019.
8
Color-coded molecular beacons for multiplex PCR screening assays.
PLoS One. 2019 Mar 18;14(3):e0213906. doi: 10.1371/journal.pone.0213906. eCollection 2019.
9
C797S, T790M and sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.
Oncotarget. 2018 Dec 21;9(100):37393-37406. doi: 10.18632/oncotarget.26446.
10
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.
J Natl Cancer Inst. 2019 Jun 1;111(6):575-583. doi: 10.1093/jnci/djy156.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验